Crescom (CEO Jaejun Lee), an artificial intelligence (AI) medical data analysis company, announced that it received the Minister of Health and Welfare Award at the '10th 2025 4th Industrial Revolution Power Korea Exhibition' held at the National Assembly Members' Hall on September 4th.
This event was hosted by the Daejeon Operations Headquarters of the 4th Industrial Revolution Power Korea and the Korea Sustainability Management Evaluation Institute, and sponsored by the Ministry of Science and ICT, the Ministry of Health and Welfare, the Ministry of Culture, Sports and Tourism, the Ministry of Agriculture, Food and Rural Affairs, the Ministry of Trade, Industry and Energy, the Ministry of Oceans and Fisheries, and the Ministry of SMEs and Startups. The event was organized to promote the realization of a human-centered smart society and the development of the ICT industry in response to the acceleration of digital transformation and changing global environments.
Crescom was honored with the award in recognition of its contributions to the advancement of domestic healthcare and the promotion of national health by improving the accuracy and efficiency of medical image interpretation through AI technology specialized in musculoskeletal diseases, and by supporting precise diagnosis and personalized healthcare management for patients.
The company's key solutions include: MediAI-BA, a bone age analysis solution (TW3·GP hybrid method); MediAI-OA, an automated quantitative knee arthritis severity analysis solution (currently being applied to all health insurance review and assessment services); and MediAI-FX, the world's first solution to detect scaphoid fractures in plain radiographs. These solutions are currently being provided to approximately 470 hospitals and clinics in Korea and abroad.
Crescom is also preparing to launch next-generation solutions targeting various musculoskeletal conditions, including skeletal measurements, spinal disorders, and ankylosing spondylitis. These products have received global regulatory certifications, including the Ministry of Food and Drug Safety (MFDS), the Malaysian Ministry of Health, and ISO 13485. Furthermore, the company is demonstrating the clinical applicability of its technologies through clinical trials and proof-of-concepts (PoCs) at major domestic university hospitals and overseas medical institutions.
CEO Lee Jae-jun said, “This award is recognition not only of Crescom’s technological achievements but also of the social value we have contributed to the healthcare field,” and added, “We will continue to provide innovative technologies that provide practical help to both patients and medical professionals by developing AI solutions specialized in the musculoskeletal system.”
- See more related articles
You must be logged in to post a comment.